SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs strong third-quarter results and upbeat outlook for AI-compute expansion are driving attention, alongside a wave of analyst upgrades. Speculation about a possible Tesla tie-up adds interest, while traders debate the companys valuation, heavy spending needs and potential share-unlock pressure.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros sharply raised preliminary quarterly revenue and gross-margin outlook, attributed to strong AI-server demand, is driving attention. Many traders see the update as evidence of growth and argue the shares are undervalued, while others question whether margins and cash flow can hold up and complain that gains are fading amid persistent volatility.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs post-earnings selloff is centered on softer-than-expected forward guidance and a reduced advertising outlook, which renewed concerns about slowing growth despite a quarterly profit beat and prompted analyst downgrades and price-target cuts. Traders are divided between expecting further downside and viewing the drop as an overreaction and a buying opportunity.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples foldable iPhone Duo preorders reportedly sold out quickly, but traders debate whether that reflects strong demand or limited launch supply. The discussion also centers on analyst downgrades and a cautious earnings outlook, with concerns about iPhone growth and valuation countered by optimism about the new device.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is drawing attention amid persistent weakness and volatile trading across Chinese equities, with traders blaming a broader rotation out of China assets and concerns about the economy, policy support, and political risk. The community is split between calling the shares a value trap and expecting a rebound, with some pointing to AI and cloud growth as potential support; no single company-specific catalyst dominates.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Traders are pointing to a Citi upgrade and finalized GENIUS Act rules for stablecoin issuers as catalysts, viewing the federal framework as supportive for Circle and USDC. The reaction is broadly bullish around the share-price rebound, though some remain concerned about USDC growth and competition.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabets selloff is fueling debate ahead of earnings: traders worry that heavy AI spending may not pay off and that AI competitors could threaten Search advertising, while others point to Cloud and Gemini potential and are buying the dip.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeers September operating updateshowing sharply higher Bitcoin production and a larger AI Cloud backloghas drawn attention, but traders are frustrated that the shares have remained weak despite the good news. The conversation is split between dip-buying optimism about mining and AI expansion and concerns about short selling, possible dilution, and broader weakness in crypto and data-center stocks.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Samsung and Micron licensing agreements have renewed focus on its patent-enforcement strategy, especially the pending USPTO response in the 912-patent appeal and the potential implications for its dispute with Google. Traders are speculating about a favorable procedural outcome, while emphasizing that it is uncertain; a possible SK Hynix deal, upcoming earnings, and the new LIGHTNING ULL DDR5 products are also in focus.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strives Bitcoin-treasury expansion and financing are the main focus, with traders discussing Bitcoin purchases funded by its SATS preferred offering and warrant proceeds. Bulls see the growing BTC holdings as amplified Bitcoin exposure, while skeptics argue that preferred dividends and share issuance could weigh on common shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After Plunging 27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Sagimet Biosciences Surges Forward With Successful Acne Clinical Data and Capital Raise

Sagimet reports positive 52-week Phase 3 trial data for denifanstat in acne patients and prices a $115 million stock offering.read more...

Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market

Equity

Sagimet’s Denifanstat produced a 57% treatment-success rate after up to 52 weeks.


Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion

Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion...

Here's Why Sagimet Biosciences Inc. (SGMT) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Sagimet Biosciences Inc. (SGMT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Wall Street Analysts Believe Sagimet Biosciences Inc. (SGMT) Could Rally 298.5%: Here's is How to Trade

The mean of analysts' price targets for Sagimet Biosciences Inc. (SGMT) points to a 298.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Sagimet Biosciences Inc. (SGMT) is a Great Momentum Stock: Should You Buy?

Does Sagimet Biosciences Inc. (SGMT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Sagimet Biosciences Inc. (SGMT) Have the Potential to Rally 241.77% as Wall Street Analysts Expect?

The mean of analysts' price targets for Sagimet Biosciences Inc. (SGMT) points to a 241.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Canaccord Genuity Group Raises Sagimet Biosciences (NASDAQ:SGMT) Price Target to $49.00

Canaccord Genuity Group raised their target price on Sagimet Biosciences from $28.00 to $49.00 and gave the stock a 'buy' rating in a research note on Monday...

Sagimet Biosciences Targets Acne, Plans U.S. Phase III for Denifanstat After $175M Raise

Sagimet Biosciences (NASDAQ:SGMT) said it is sharpening its strategic focus on developing differentiated therapies for patients with moderate to severe acne, with plans to advance its lead fatty acid...

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Bullish Sentiment

<ul class="summary-bullets"><li>Total acne lesions fell 72% and inflammatory lesions declined 77% in a Phase 3 extension study in China.</li><li>Its Phase 3 study in the U.S. is expected to enroll about 800 patients aged 12 and older.</li><li>Sagimet is raising $115 million at $10 per share, a 7% premium over Tuesday’s close.</li></ul>Shares of Sagimet Biosciences (<a class="mention" data-mention="$SGMT" data-symbol-id="SGMT" href="https://stocktwits.com/symbol/SGMT" target="_blank">SGMT</a>) rose 13% in pre-market trading on Wednesday after the biotech firm reported promising long-term results for its experimental acne drug and raised fresh capital to fund its upcoming U.S. Phase 3 trial.Sagimet’s Denifanstat produced a 57% treatment-success rate after up to 52 weeks, while total acne lesions fell 72% and inflammatory lesions declined 77% in a Phase 3 extension study in China conducted by Sagimet’s licensing partner, Ascletis.Denifanstat is a once-daily oral drug that blocks fatty acid synthase (FASN), an enzyme that causes acne. The drug was generally well tolerated, with no patients permanently stopping treatment because of adverse events.<h2 class="st-heading-2">U.S. Phase 3 Trial To Involve 800 Patients</h2>The results come as Sagimet prepares to begin screening patients in October for its Phase 3 study in the U.S. The trial is expected to enroll about 800 patients aged 12 and older, including roughly 450 adolescents.Patients will receive either Denifanstat or placebo for 12 weeks, with around 530 patients eligible to continue into a 40-week extension study. Sagimet said Denifanstat could potentially become the first oral acne treatment with a new mechanism of action approved in more than 40 years.<h2 class="st-heading-2">Sagimet Raises $115 Million To Fund Phase 3</h2>To fund its U.S. study, Sagimet announced that it is raising $115 million at $10 per share, along with pre-funded warrants. This represents a 7% premium over Tuesday’s close.Beyond funding the Phase 3 trial and a potential drug launch, the proceeds will also support TVB-3567, its other acne drug in development, through Phase 2 results and advance its topical FASN inhibitor program toward an Investigational New Drug (IND) application.Sagimet reported $257.6 million in cash, cash equivalents and marketable securities as of June 30, which the company expects would fund operations through 2028.<h2 class="st-heading-2">Retail’s Take On <a class="mention" data-mention="$SGMT" data-symbol-id="SGMT" href="https://stocktwits.com/symbol/SGMT" target="_blank">SGMT</a></h2>Retail sentiment surrounding&nbsp;<a href="https://stocktwits.com/symbol/SGMT">SGMT</a> on Stocktwits remained ‘extremely bullish’ over the past 24 hours amid ‘high’ message volumes. <a class="mention" data-mention="$SGMT" data-symbol-id="SGMT" href="https://stocktwits.com/symbol/SGMT" target="_blank">SGMT</a> was also among the top trending tickers at the time of writing.The stock has seen significant buying interest so far this year, gaining 56%.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/redwire-joins-growing-orbital-data-center-race-with-sophia-days-after-980-m-space-force-contract-selection/cZMFdJ7RBhh">&nbsp;Redwire Joins Growing Orbital Data Center Race With Sophia Days After $980M Space Force Contract Selection</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A researcher works in the clinical-stage biopharmaceutical company Xencors new laboratory in Pasadena.

Sagimet’s Denifanstat produced a 57% treatment-success rate after up to 52 weeks.

Why Is SGMT Stock Surging Premarket Today?

Sagimet Biosciences Inc

SPDR S&P Biotech ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

Tesla ($TSLA) reports earnings after the close today. What do you expect?

Stocktwits

) reports earnings after the close today. What do you expect?

Current Price	$9.82
Prev Close	$9.74
Open	$9.78
Dividend Yield	0.00%
50-Day Moving Average	$9.93
Beta	1.99
Avg. Volume	1.37M
PE Ratio	-7.60

52-Week High	$11.45
52-Week Low	$4.50
Market Capitalization	$685.12M
EPS (Annual)	-$1.58
Price to Book	2.35
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SGMT Fundamentals